Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373425
Status:
COMPLETED
Last Update Posted:
2015-09-17
First Post:
2006-09-07
Brief Title:
A Study of Erlotinib Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma NSCLC Patients Who Have Epidermal Growth Factor Receptor EGFR Positive Tumors
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-07
First Submit QC Date:
September 7 2006
Study First Post Date:
2006-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-06-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-01
Last Update Post Date:
2015-09-17
Last Update Post Date Type:
ESTIMATED